Why the Afterpay (ASX:APT) share price is tumbling today

The ASX 200 is pushing 1.5% higher on Thursday so why has the Afterpay Ltd (ASX: APT) share price tanked 5.7%?

| More on:
A man recoils from his empty wallet in horror, indicating a major share price fall.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Afterpay Ltd (ASX: APT) share price has struggled in the new year, falling almost 10% in just the last two ASX market sessions. 

Tech-heavy Nasdaq selling off 

The Nasdaq Composite (INDEXNASDAQ: .IXIC) has fallen 0.61% despite the S&P 500 Index (INDEXSP: .INX) and Dow Jones Industrial Average (INDEXDJX: .DJI) pushing a respective 0.57% and 1.44% higher. 

The broad weakness in the tech sector is likely a result of changes in the balance of power in US politics. With the Democrats taking control of the Senate raising the threat of increased regulation. 

For two years, a Republican-controlled Senate bottled up a vast majority of legislation coming out of the Democratic-controlled House of Representatives. The control of the Senate will now spell good news for incoming President Joe Biden's agenda on issues including healthcare, the environment, government reform and the economy. 

Experts see this victory as a potential broad rotation away from tech shares into more cyclical sectors such as banking, consumer staples and materials, similar to what the market experienced during November last year. 

S&P/ASX Information Technology (ASX: XIJ) follows suit

The S&P/ASX information Technology index has followed suit with sharp losses today, down 3.15% at the time of writing.

Some of the best performing ASX 200 tech shares from last year, including Xero Limited (ASX: XRO), Zip Co Ltd (ASX: Z1P) and Afterpay have struggled the most today. But taking a look at the bigger picture, the Afterpay share price ran more than 300% in 2020. 

The broader market is following the US, with the ASX 200 gaining 1.65%, at the time of writing, and more cyclical sectors such as financials, energy and materials running much higher. 

The Afterpay growth story in 2021 

Despite the Afterpay share price tanking this week, the company has a number of promising plans for the year ahead. This includes the pending approval for the acquisition of Pagantis in Europe and development of a strategy to tackle the South Asia market. 

Big brokers have also been bullish for the Afterpay share price, with Credit Suisse initiating a $124.00 price target in early December of last year. The broker anticipates a strong growth outlook to underpin strong financial performance and investor returns. 

Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Xero and ZIPCOLTD FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »